Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography

JACC: Cardiovascular Interventions

Volumn 4, Issue 9, 2011, Pages 992-1001

  Gomez Lara, Josep ^a   Radu, Maria ^a   Brugaletta, Salvatore ^a   Farooq, Vasim ^a   Diletti, Roberto ^a   Onuma, Yoshinobu ^a   Windecker, Stephan ^b   Thuesen, Leif ^c   McClean, Dougal ^d   Koolen, Jacques ^e   Whitbourn, Robert ^f   Dudek, Dariusz ^g   Smits, Pieter C ^h   Regar, Evelyn ^a   Veldhof, Susan ⁱ   Rapoza, Richard ⁱ   Ormiston, John A ^j   Garcia Garcia, Hector M ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d CHRISTCHURCH HOSPITAL   (New Zealand)

^e CATHARINA HOSPITAL   (Netherlands)

^f ST VINCENT S HOSPITAL   (Australia)

^g JAGIELLONIAN UNIVERSITY   (Poland)

^h Maasstad Hospital Rotterdam   (Netherlands)

ⁱ ABBOTT LABORATORIES   (United States)

^j AUCKLAND CITY HOSPITAL   (New Zealand)

more..

Author keywords

bioresorbable scaffolds; incomplete stent; late acquired incomplete stent; optical coherence tomography; strut apposition; uncovered struts

Indexed keywords

EVEROLIMUS;

ADULT; AGED; ARTICLE; BIORESORBABLE VASCULAR SCAFFOLD; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; INTRAVASCULAR ULTRASOUND; MALAPPOSED STRUT; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL;

AGED; ANGIOPLASTY, BALLOON, CORONARY; AUSTRALIA; BIOCOMPATIBLE MATERIALS; CARDIOVASCULAR AGENTS; DRUG-ELUTING STENTS; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PROSTHESIS DESIGN; SIROLIMUS; THROMBOSIS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; UNITED STATES;

EID: 80052998014     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.03.020     Document Type: Article

References (30)

1. K. Tanabe, P.W. Serruys, and M. Degertekin Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial Circulation 111 2005 900 905 (Pubitemid 40279892)
2. M. Degertekin, P.W. Serruys, and K. Tanabe Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis Circulation 108 2003 2747 2750 (Pubitemid 37498975)
3. Y. Ozaki, M. Okumura, and T.F. Ismail The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study Eur Heart J 31 2010 1470 1476
4. D. Matsumoto, J. Shite, and T. Shinke Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography Eur Heart J 28 2007 961 967 (Pubitemid 47343895)
5. S. Cook, P. Wenaweser, and M. Togni Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation Circulation 115 2007 2426 2434 (Pubitemid 46717965)
6. A.V. Finn, M. Joner, and G. Nakazawa Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization Circulation 115 2007 2435 2441 (Pubitemid 46717966)
7. P.W. Serruys, J.A. Ormiston, and Y. Onuma A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 2009 897 910
8. J.A. Ormiston, P.W. Serruys, and E. Regar A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial Lancet 371 2008 899 907 (Pubitemid 351384734)
9. T. Okamura, S. Garg, and J.L. Gutierrez-Chico In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial EuroIntervention 5 2010 932 938
10. J. Gomez-Lara, S. Brugaletta, and R. Diletti A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds Eur Heart J 32 2011 294 304
11. S. Brugaletta, H.M. Garcia-Garcia, and R. Diletti Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study EuroIntervention 6 2010 1110 1116
12. P.W. Serruys, Y. Onuma, and J.A. Ormiston Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes Circulation 122 2010 2301 2312
13. J. Cohen A coefficient of agreement for nominal scales Educ Psychol Meas 20 1960 37 46
14. J. Fleiss Statistical Methods for Rates and Proportions 2nd edition 1981 John Wiley New York, NY
15. J. Tanigawa, P. Barlis, K. Dimopoulos, M. Dalby, P. Moore, and C. Di Mario The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography Int J Cardiol 134 2009 180 188
16. J.S. Kim, I.K. Jang, and C. Fan Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial J Am Coll Cardiol Intv 2 2009 1240 1247
17. T. Kubo, T. Imanishi, and H. Kitabata Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study J Am Coll Cardiol Img 1 2008 475 484 (Pubitemid 351998679)
18. J. Tanigawa, P. Barlis, K. Dimopoulos, and C. Di Mario Optical coherence tomography to assess malapposition in overlapping drug-eluting stents EuroIntervention 3 2008 580 583
19. G. Guagliumi, G. Musumeci, and V. Sirbu Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents J Am Coll Cardiol Intv 3 2010 531 539
20. D. Murakami, M. Takano, and M. Yamamoto Advanced neointimal growth is not associated with a low risk of in-stent thrombus Optical coherence tomographic findings after first-generation drug-eluting stent implantation Circ J 73 2009 1627 1634
21. H. Katoh, J. Shite, and T. Shinke Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography Circ J 73 2009 1033 1037
22. K. Ishigami, S. Uemura, and Y. Morikawa Long-term follow-up of neointimal coverage of sirolimus-eluting stents: evaluation with optical coherence tomography Circ J 73 2009 2300 2307
23. B.E. Bouma, G.J. Tearney, and H. Yabushita Evaluation of intracoronary stenting by intravascular optical coherence tomography Heart 89 2003 317 320 (Pubitemid 36241548)
24. J. Ako, Y. Morino, and Y. Honda Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis J Am Coll Cardiol 46 2005 1002 1005 (Pubitemid 41316506)
25. M.K. Hong, G.S. Mintz, and C.W. Lee Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up Circulation 113 2006 414 419 (Pubitemid 43803203)
26. Y. Tsuchiya, A.J. Lansky, and R.A. Costa Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials) Am J Cardiol 98 2006 464 469 (Pubitemid 44177577)
27. A. Miyazawa, J. Ako, and Y. Hongo Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR Am Heart J III:155 2008 108 113 (Pubitemid 350234763)
28. Y. Oikawa, J. Yajima, and M. Costa Intravascular ultrasound, angioscopic and histopathological characterization of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: insights into potential "thromborestenosis" phenomenon EuroIntervention 6 2010 380 387
29. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202 (Pubitemid 43929240)
30. H. Otake, J. Shite, and J. Ako Local determinants of thrombus formation following sirolimus-eluting stent implantation assessed by optical coherence tomography J Am Coll Cardiol Intv 2 2009 459 466